Ibotta Inc. IBTA 深 滬
等待開盤 12-19 09:30:00 美东时间
21.80
-0.150
-0.68%
華盛通- 最 高22.31
- 今 開22.00
- 成交量 39.47万股
- 最 低 21.52
- 昨 收 21.95
- 總市值 5.80亿
- 52周最高 76.00
- 市盈率 靜 8.52
- 換手率 0.00%
- 52周最低 20.60
- 委 比 4.17%
- 總股本 2658.28万
- 歷史最高 117.59
- 量 比 0.86
- 振 幅 3.60%
- 歷史最低 20.60
- 每 手 1
- 風險率 15.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cathie Wood Dumps $11.6 Million Worth Of Tesla Stock: Here Is What Ark Purchased Instead
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
11-27 10:02
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
B of A Securities Maintains Underperform on Ibotta, Lowers Price Target to $22
B of A Securities analyst Curtis Nagle maintains Ibotta (NYSE:IBTA) with a Underperform and lowers the price target from $24 to $22.
11-13 20:50
Why Cisco Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Shares of Cisco Systems, Inc. (NASDAQ:CSCO) rose sharply in pre-market trading ...
11-13 18:16
Ibotta shares are trading lower. The company reported Q3 financial results.
Ibotta shares are trading lower. The company reported Q3 financial results.
11-13 05:18
Ibotta Sees Q4 Sales $80.000M-$85.000M vs $84.148M Est
Ibotta (NYSE:IBTA) sees Q4 sales of $80.000 million-$85.000 million vs $84.148 million analyst estimate.
11-13 05:13
Ibotta Q3 Adj. EPS $0.56 Beats $0.00 Estimate, Sales $83.260M Beat $81.906M Estimate
Ibotta (NYSE:IBTA) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.00 by 18566.67 percent. This is a 40.43 percent decrease over earnings of $0.94 per share from the same
11-13 05:13
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
A Glimpse of Ibotta's Earnings Potential
Ibotta (NYSE:IBTA) is preparing to release its quarterly earnings on Wednesday,...
11-11 23:02
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
